Company
Granata Bio
- Business model
- B2B
- Legal name
- Granata Bio
Claim, correct or request removal
Record updated 29 September 2026
About
Biopharma platform developing and commercializing IVF medication
Funding snapshot
- Total raised
- $23.9MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $13.8M2024-12-19
Funding rounds
- Round, 2024
- $13.8M2024-12-19, SEC form D sold, 3 investors
- Round, 2023
- $10.1M2023-10-25, SEC form D sold, 10 investors
Loading relationship preview